MYELODYSPLASTIC SYNDROMES MANAGEMENT AND TREATMENT: A CONCEPTUAL FRAMEWORK

被引:0
|
作者
Bentley, T. [1 ]
Broder, M. [1 ]
DeCristofaro, A. [1 ]
Megaffin, S. [2 ]
Petrone, M. [2 ]
McKearn, T. [2 ]
Kurtin, S. [3 ]
Cogle, C. [4 ]
机构
[1] Partnership Hlth Serv Res, Beverly Hills, CA USA
[2] Onconova Therapeut Inc, Newtown, PA USA
[3] Univ Arizona, Ctr Canc, Tucson, AZ USA
[4] Univ Florida, Coll Med, Div Hematol & Oncol, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1606
引用
收藏
页码:622 / 623
页数:2
相关论文
共 50 条
  • [41] DANAZOL IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
    BUZAID, AC
    GAREWAL, HS
    LIPPMAN, SM
    DURIE, BGM
    GREENBERG, BR
    CLINICAL RESEARCH, 1987, 35 (01): : A186 - A186
  • [42] Decitabine in the treatment of myelodysplastic syndromes
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Issa, Jean-Pierre
    Ravandi, Farhad
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (01) : 9 - 22
  • [43] Injectable Hypomethylating Agents for Management of Myelodysplastic Syndromes: Patients' Perspectives on Treatment
    Zeidan, Amer M.
    Jayade, Sayeli
    Schmier, Jordana
    Botteman, Marc
    Hassan, Audrey
    Ruiters, Desiree
    Hill, Kala
    Joshi, Namita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E185 - E198
  • [44] THE MYELODYSPLASTIC SYNDROMES - BIOLOGY AND IMPLICATIONS FOR MANAGEMENT
    LIST, AF
    GAREWAL, HS
    SANDBERG, AA
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1424 - 1441
  • [45] Novel agents for the management of myelodysplastic syndromes
    Meletis, John
    Viniou, Nora
    Terpos, Evangelos
    MEDICAL SCIENCE MONITOR, 2006, 12 (09): : RA194 - RA206
  • [46] Management of Myelodysplastic Syndromes: 2008 Update
    Scott, Bart L.
    Estey, Eli
    ONCOLOGY-NEW YORK, 2008, 22 (12): : 1344 - 1352
  • [47] Guidelines for the management of adult myelodysplastic syndromes
    Killick, Sally B.
    Ingram, Wendy
    Culligan, Dominic
    Enright, Helen
    Kell, Jonathan
    Payne, Elspeth M.
    Krishnamurthy, Pramila
    Kulasekararaj, Austin
    Raghavan, Manoj
    Stanworth, Simon J.
    Green, Simone
    Mufti, Ghulam
    Quek, Lynn
    Cargo, Catherine
    Jones, Gail L.
    Mills, Juliet
    Sternberg, Alex
    Wiseman, Daniel H.
    Bowen, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) : 267 - 281
  • [48] Azacitidine in the management of patients with myelodysplastic syndromes
    Khan, Cyrus
    Pathe, Neeta
    Fazal, Salman
    Lister, John
    Rossetti, James M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (06) : 355 - 373
  • [49] Individualized management and therapy of myelodysplastic syndromes
    Stauder, Reinhard
    Wimazal, Friedrich
    Noesslinger, Thomas
    Krieger, Otto
    Sperr, Wolfgang R.
    Sill, Heinz
    Pfeilstoecker, Michael
    Valent, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (17-18) : 523 - 537
  • [50] Management of myelodysplastic syndromes in 2019: An update
    Comont, T.
    Delavigne, K.
    Cougoul, P.
    Bertoli, S.
    Delabesse, E.
    Fenaux, P.
    Beyne-Rauzy, O.
    REVUE DE MEDECINE INTERNE, 2019, 40 (09): : 581 - 589